Literature DB >> 11134534

PKN delays mitotic timing by inhibition of Cdc25C: possible involvement of PKN in the regulation of cell division.

K Misaki1, H Mukai, C Yoshinaga, K Oishi, T Isagawa, M Takahashi, K Ohsumi, T Kishimoto, Y Ono.   

Abstract

The role of PKN, a fatty acid- and Rho small GTPase-activated protein kinase, in cell-cycle regulation was analyzed. Microinjection of the active form of PKN into a Xenopus embryo caused cleavage arrest, whereas normal cell division proceeded in the control embryo microinjected with buffer or the inactive form of PKN. Exogenous addition of the active form of PKN delayed mitotic timing in Xenopus egg cycling extracts judging by morphology of sperm nuclei and Cdc2/cyclin B histone H1 kinase activity. The kinase-negative form of PKN did not affect the timing, suggesting that delayed mitotic timing depends on the kinase activity of PKN. The dephosphorylation of Tyr-15 of Cdc2 was also delayed in correlation with Cdc2/cyclin B histone H1 kinase activation in extracts containing active PKN. The Cdc25C activity for the dephosphorylation of Tyr-15 in Cdc2 was suppressed by pretreatment with the active form of PKN. Furthermore, PKN efficiently phosphorylated Cdc25C in vitro, indicating that PKN directly inhibits Cdc25C activity by phosphorylation. These results suggest that PKN plays a significant role in the control of mitotic timing by inhibition of Cdc25C.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11134534      PMCID: PMC14555          DOI: 10.1073/pnas.98.1.125

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Regulation of the cdc25 protein during the cell cycle in Xenopus extracts.

Authors:  A Kumagai; W G Dunphy
Journal:  Cell       Date:  1992-07-10       Impact factor: 41.582

2.  Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1.

Authors:  Y Zeng; K C Forbes; Z Wu; S Moreno; H Piwnica-Worms; T Enoch
Journal:  Nature       Date:  1998-10-01       Impact factor: 49.962

3.  Characterization of the interaction between RhoA and the amino-terminal region of PKN.

Authors:  H Shibata; H Mukai; Y Inagaki; Y Homma; K Kimura; K Kaibuchi; S Narumiya; Y Ono
Journal:  FEBS Lett       Date:  1996-05-06       Impact factor: 4.124

4.  Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15.

Authors:  P R Mueller; T R Coleman; A Kumagai; W G Dunphy
Journal:  Science       Date:  1995-10-06       Impact factor: 47.728

5.  A rho-like protein is involved in the organisation of the contractile ring in dividing sand dollar eggs.

Authors:  I Mabuchi; Y Hamaguchi; H Fujimoto; N Morii; M Mishima; S Narumiya
Journal:  Zygote       Date:  1993-11       Impact factor: 1.442

6.  Cdc25 inhibited in vivo and in vitro by checkpoint kinases Cds1 and Chk1.

Authors:  B Furnari; A Blasina; M N Boddy; C H McGowan; P Russell
Journal:  Mol Biol Cell       Date:  1999-04       Impact factor: 4.138

7.  Mutational analysis of the regulatory mechanism of PKN: the regulatory region of PKN contains an arachidonic acid-sensitive autoinhibitory domain.

Authors:  C Yoshinaga; H Mukai; M Toshimori; M Miyamoto; Y Ono
Journal:  J Biochem       Date:  1999-09       Impact factor: 3.387

8.  Role of citron kinase as a target of the small GTPase Rho in cytokinesis.

Authors:  P Madaule; M Eda; N Watanabe; K Fujisawa; T Matsuoka; H Bito; T Ishizaki; S Narumiya
Journal:  Nature       Date:  1998-07-30       Impact factor: 49.962

9.  Identification of a putative target for Rho as the serine-threonine kinase protein kinase N.

Authors:  M Amano; H Mukai; Y Ono; K Chihara; T Matsui; Y Hamajima; K Okawa; A Iwamatsu; K Kaibuchi
Journal:  Science       Date:  1996-02-02       Impact factor: 47.728

10.  Meiosis-specific cell cycle regulation in maturing Xenopus oocytes.

Authors:  K Ohsumi; W Sawada; T Kishimoto
Journal:  J Cell Sci       Date:  1994-11       Impact factor: 5.285

View more
  12 in total

1.  TGF-beta-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest.

Authors:  Neil A Bhowmick; Mayshan Ghiassi; Mary Aakre; Kimberly Brown; Vikas Singh; Harold L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

2.  Intracellular targets for a phosphotyrosine peptidomimetic include the mitotic kinesin, MCAK.

Authors:  Rong Huang; Hyunju Oh; Allison Arrendale; Victoria A Martin; Jacob Galan; Eric J Workman; Jane R Stout; Claire E Walczak; W Andy Tao; Richard F Borch; Robert L Geahlen
Journal:  Biochem Pharmacol       Date:  2013-07-04       Impact factor: 5.858

3.  Rho GTPases regulate PRK2/PKN2 to control entry into mitosis and exit from cytokinesis.

Authors:  Anja Schmidt; Joanne Durgan; Ana Magalhaes; Alan Hall
Journal:  EMBO J       Date:  2007-03-01       Impact factor: 11.598

4.  Development of an intracellularly acting inhibitory peptide selective for PKN.

Authors:  Kazuhiro Shiga; Kentaro Takayama; Shiroh Futaki; Jessica E Hutti; Lewis C Cantley; Katsuko Ueki; Yoshitaka Ono; Hideyuki Mukai
Journal:  Biochem J       Date:  2009-12-23       Impact factor: 3.857

5.  A rho-binding protein kinase C-like activity is required for the function of protein kinase N in Drosophila development.

Authors:  Martha Betson; Jeffrey Settleman
Journal:  Genetics       Date:  2007-05-16       Impact factor: 4.562

6.  Enzyme kinetics and distinct modulation of the protein kinase N family of kinases by lipid activators and small molecule inhibitors.

Authors:  Matthew D Falk; Wei Liu; Ben Bolaños; Keziban Unsal-Kacmaz; Anke Klippel; Stephan Grant; Alexei Brooun; Sergei Timofeevski
Journal:  Biosci Rep       Date:  2014-04-01       Impact factor: 3.840

7.  Impaired lymphocyte trafficking in mice deficient in the kinase activity of PKN1.

Authors:  Rana Mashud; Akira Nomachi; Akihide Hayakawa; Koji Kubouchi; Sally Danno; Takako Hirata; Kazuhiko Matsuo; Takashi Nakayama; Ryosuke Satoh; Reiko Sugiura; Manabu Abe; Kenji Sakimura; Shigeharu Wakana; Hiroyuki Ohsaki; Shingo Kamoshida; Hideyuki Mukai
Journal:  Sci Rep       Date:  2017-08-09       Impact factor: 4.379

8.  Adiponectin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of AMPK/Sirt1/PGC-1α signaling.

Authors:  Bingqing Huang; Xixi Cheng; Dan Wang; Meiyu Peng; Zhenyi Xue; Yurong Da; Ning Zhang; Zhi Yao; Min Li; Aimin Xu; Rongxin Zhang
Journal:  Oncotarget       Date:  2014-07-15

9.  PKN3 is the major regulator of angiogenesis and tumor metastasis in mice.

Authors:  Hideyuki Mukai; Aiko Muramatsu; Rana Mashud; Koji Kubouchi; Sho Tsujimoto; Tsunaki Hongu; Yasunori Kanaho; Masanobu Tsubaki; Shozo Nishida; Go Shioi; Sally Danno; Mona Mehruba; Ryosuke Satoh; Reiko Sugiura
Journal:  Sci Rep       Date:  2016-01-08       Impact factor: 4.379

10.  PKN1 kinase-negative knock-in mice develop splenomegaly and leukopenia at advanced age without obvious autoimmune-like phenotypes.

Authors:  Salman Mahmud Siddique; Koji Kubouchi; Yuka Shinmichi; Nana Sawada; Reiko Sugiura; Yasushi Itoh; Shunsuke Uehara; Kanae Nishimura; Shunsuke Okamura; Hiroyuki Ohsaki; Shingo Kamoshida; Yusuke Yamashita; Shinobu Tamura; Takashi Sonoki; Hiroshi Matsuoka; Tomoo Itoh; Hideyuki Mukai
Journal:  Sci Rep       Date:  2019-09-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.